Recurrent Anaplastic Large Cell Lymphoma (DBCOND0045771)
Identifiers
- Synonyms
- Not Available
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT04074746 Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas treatment 1 / 2 active_not_recruiting NCT03075553 Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma treatment 2 terminated NCT01035463 Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma treatment 1 / 2 completed NCT03278782 Study of Pembrolizumab (MK-3475) in Combination With Romidepsin treatment 1 / 2 active_not_recruiting NCT04774068 Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas treatment 1 active_not_recruiting NCT02572453 Phase 2 Study of AT13387 (Onalespib) in ALK+ ALCL, MCL, and BCL-6+ DLBCL treatment 2 terminated NCT03598998 Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas treatment 1 / 2 active_not_recruiting NCT01590732 Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma treatment 1 completed NCT01028716 Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies treatment 2 terminated NCT03017820 VSV-hIFNbeta-NIS in Treating Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma treatment 1 recruiting